共 84 条
[1]
McKhann GM(2011)The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging—Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 263-269
[2]
Knopman DS(2010)Target-specific PET probes for neurodegenerative disorders related to dementia J Nucl Med Off Publ Soc Nucl Med 51 1418-1430
[3]
Chertkow H(2007)Recent advances in the development of amyloid imaging agents Curr Top Med Chem 7 1773-1789
[4]
Kadir A(2009)Advances in molecular imaging for the diagnosis of dementia Expert Opin Med Diagn 3 705-716
[5]
Nordberg A(2004)Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B Ann Neurol 55 306-319
[6]
Furumoto S(2010)F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial Ann Neurol 68 319-329
[7]
Okamura N(2011)Cerebral amyloid-beta PET with florbetaben ( Lancet Neurol 10 424-435
[8]
Iwata R(2011)F) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study Jama 305 275-283
[9]
Yanai K(2010)Use of florbetapir-PET for imaging beta-amyloid pathology J Neurochem 114 784-794
[10]
Arai H(2007)Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand Neurology 68 1718-1725